Monoamine oxidase inhibitor poisoning resulting from Internet misinformation on illicit substances.
D Eric Brush, Steven B Bird, Edward W Boyer
Journal of Toxicology Clinical Toxicology 2004 DOI: 10.1081/clt-120030949 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Case study Case report Peer reviewed |
|---|---|
| Sample size | 1 |
| Population | Adolescent |
| Keywords | Drug misinformation Online drug advice Internet misinformation False drug information Drug disinformation Misleading drug information Adolescent health Youth health Teen health Pediatric health Young adult health Substance poisoning Drug overdose Drug toxicity Intoxication Drug-induced illness Critical health event Online safety Internet safety Digital safety Online risks Cyber safety |
| Citations | 119 |
| Key findings | An adolescent's use of Internet-based drug information led to severe poisoning from combining harmaline and 5-MeO-DMT. |
Abstract
The Internet may represent a new mechanism by which adolescents initiate the use of illicit substances. The existence of multiple partisan websites providing misinformation regarding the safety of these substances may lead to an increase in unsafe behavior among this age group. Adverse outcomes related to Internet-based drug information are rarely identified. We report a case of an adolescent whose use of the Internet to obtain drug information led to severe poisoning from the combination of a monoamine oxidase inhibitor, harmaline, and a hallucinogenic tryptamine, 5-methoxydimethyltryptamine (5-MeO-DMT).
Citations in the library
Cited by 43
- The hallucinogenic world of tryptamines: an updated review. Archives of Toxicology August 1, 2015
- Clinical toxicology of newer recreational drugs Clinical Toxicology October 1, 2011
- Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids Addiction December 20, 2006
- Recreational Use, Analysis and Toxicity of Tryptamines Current Neuropharmacology December 10, 2014
- The globalization of ayahuasca: Harm reduction or benefit maximization? International Journal of Drug Policy December 5, 2006
and 38 more in the library
Cites 3
- Pharmahuasca: Human Pharmacology of Oral DMT Plus Harmine Journal of Psychoactive Drugs April 1, 1999
- Ayahuasca Preparations and Serotonin Reuptake Inhibitors: A Potential Combination for Severe Adverse Interactions Journal of Psychoactive Drugs December 1, 1998
- Pharmepéna-Psychonautics: Human intranasal, sublingual and oral pharmacology of 5-methoxy-N,N-dimethyl-tryptamine. Journal of Psychoactive Drugs 2001